يعرض 141 - 160 نتائج من 14,950 نتيجة بحث عن '(( ct largest decrease ) OR ((( ((i large) OR (b large)) decrease ) OR ( via large increase ))))*', وقت الاستعلام: 0.74s تنقيح النتائج
  1. 141
  2. 142

    DataSheet_1_A nationwide analysis of the treatment patterns, survival, and medical costs in Korean patients with relapsed or refractory diffuse large B-cell lymphoma.docx حسب Jeong-Yeon Cho (11787386)

    منشور في 2024
    "…Background<p>Approximately one-third of patients with diffuse large B-cell lymphoma (DLBCL) are refractory to treatment or experience relapse after initial therapy. …"
  3. 143

    Fig 1 - حسب Sue E. Moore (2932644)

    منشور في 2022
  4. 144

    Image2_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.JPEG حسب Chaofeng Zhang (845343)

    منشور في 2024
    "…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). However, the mechanisms by which CISD2 regulates the occurrence and development of DLBCL remain to be fully elucidated.…"
  5. 145

    Image_2_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.jpeg حسب Qikai Zhang (6905096)

    منشور في 2022
    "…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …"
  6. 146

    Image_4_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.jpeg حسب Qikai Zhang (6905096)

    منشور في 2022
    "…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …"
  7. 147

    Image_3_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.jpeg حسب Qikai Zhang (6905096)

    منشور في 2022
    "…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …"
  8. 148

    Supplementary Material for: STAT3 Promotes Cell Proliferation by Potentiating the CCL4 Transcriptional Activity in Diffuse Large B-Cell Lymphoma حسب Xiao S. (11834801)

    منشور في 2021
    "…However, the underlying mechanism of STAT3 in the pathogenesis of diffuse large B-cell lymphoma (DLBCL) has yet to be established. …"
  9. 149
  10. 150
  11. 151
  12. 152

    Predicting Electrophoretic Mobility of Proteoforms for Large-Scale Top-Down Proteomics حسب Daoyang Chen (4732431)

    منشور في 2020
    "…Our results also indicate that N-terminal acetylation and phosphorylation both decrease the proteoforms’ charge by roughly one charge unit.…"
  13. 153
  14. 154
  15. 155
  16. 156
  17. 157
  18. 158
  19. 159
  20. 160

    Table_1_Clinical Features of 50 Patients With Primary Adrenal Lymphoma.DOCX حسب Yan Wang (15435)

    منشور في 2020
    "…Computed tomography showed that 42 (84%) patients had signs of infiltration. Diffuse large B-cell lymphoma was present in 44 (88%) patients. …"